Application scope of apolipoprotein C3 assay kit

Apolipoprotein C3 (ApoC3) is a key regulatory factor in lipid metabolism, and its abnormal levels are closely related to various metabolic diseases. The ApoC3 assay kit provides important basis for clinical diagnosis, disease monitoring, and drug development by detecting the content of ApoC3 in serum or plasma. The main application scope of this reagent kit is as follows:

1、 Clinical diagnosis and disease assessment

Mechanism of hypertriglyceridemia (HTG): ApoC3 inhibits lipoprotein lipase (LPL) activity, leading to impaired triglyceride (TG) metabolism.

Application: Assist in the diagnosis of familial hypertriglyceridemia (FHTG).

Assess the risk of cardiovascular disease (CVD) in HTG patients.

Atherosclerotic cardiovascular disease (ASCVD) mechanism: The increase of ApoC3 level is related to the small and dense particles of low-density lipoprotein cholesterol (LDL-C) and the impairment of high-density lipoprotein cholesterol (HDL-C) function.

Application: Evaluate CVD risk, especially in patients with mixed dyslipidemia.

Monitor changes in ApoC3 after statin therapy and predict therapeutic efficacy.

The mechanism of metabolic syndrome (MetS): ApoC3 levels are associated with MetS core features such as insulin resistance, obesity, and hypertension.

Application: Assist in diagnosing MetS and evaluating the degree of metabolic disorders.

Monitor the effectiveness of lifestyle interventions or medication treatments.

Mechanism of pancreatitis: Severe HTG (TG>1000 mg/dL) is an important trigger for acute pancreatitis, and elevated ApoC3 levels are associated with increased risk of pancreatitis.

Application: Screening high-risk populations for HTG related pancreatitis.

Monitor blood lipid changes in patients with pancreatitis and guide treatment.

2、 Disease monitoring and prognostic evaluation

Application of cardiovascular disease risk stratification: combined with LDL-C HDL-C、 Optimize the CVD risk assessment model using non-HDL-C and other indicators.

Predicting the risk of major adverse cardiovascular events (MACE) in ASCVD patients.

Diabetes and its complication mechanism: ApoC3 level is related to blood sugar control and microvascular complications (such as diabetes nephropathy) in type 2 diabetes (T2DM) patients.

Application: Evaluate the risk of dyslipidemia in T2DM patients.

Monitor the progress of complications of diabetes.

Liver disease mechanism: The liver is the main site of ApoC3 synthesis, and liver disease (such as non-alcoholic fatty liver disease NAFLD) can lead to abnormal levels of ApoC3.

Application: Assist in the diagnosis of NAFLD and evaluate the degree of liver injury.

Monitor the metabolic improvement after liver disease treatment.

3、 Drug development and treatment monitoring

Development and application of new lipid-lowering drugs: Evaluation of the regulatory effect of antisense oligonucleotides (such as Volanesorsen), PCSK9 inhibitors, and other drugs on ApoC3 levels.

Screening targeted therapeutic drugs for ApoC3.

Individualized treatment guidance application: Adjust the dosage of lipid-lowering drugs (such as statins and betas) according to ApoC3 levels.

Optimize the combination therapy regimen to improve treatment efficacy.

4、 Population screening and health management

Application of high-risk population screening: Screening HTG, MetS, CVD high-risk populations to achieve early intervention.

Assess the genetic risk of patients with familial dyslipidemia.

Health examination application: As a supplementary indicator for blood lipid profile testing, it comprehensively evaluates the lipid metabolism status.

Provide personalized health advice to reduce the risk of diseases.

5、 Technical advantages and clinical value

Technical advantages: High sensitivity: detection limit as low as 0.1 mg/dL, suitable for micro sample analysis.

Multi party legal compatibility: supports various technical platforms such as immunoturbidimetry and enzyme-linked immunosorbent assay (ELISA).

Clinical value: Risk prediction: ApoC3 level is an independent CVD risk predictor independent of traditional lipid indicators such as LDL-C and HDL-C.

Mechanism exploration: Provide key data for the molecular mechanism research of lipid metabolism disorders.

6、 Summary

The ApoC3 assay kit plays an important role in the diagnosis of dyslipidemia, CVD risk assessment, monitoring of metabolic diseases, and drug development by accurately detecting ApoC3 levels. Its clinical application can optimize disease management strategies and provide a basis for personalized treatment, making it an important tool for modern precision medicine.

双语对照

笔记